Advertisement

Topics

 Taro Pharmaceutical Industries Ltd. Company Profile

12:42 EST 21st January 2019 | BioPortfolio


News Articles [563 Associated News Articles listed on BioPortfolio]

Taro to Announce First Quarter Results on August 9, 2018

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on T...

Taro Announces Completion of $250 Million Share Repurchase Program

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it has completed its $250 million share repurchase program. The company bought back 2,493,378 of its ordinary...

Taro Terminates Agreement with NovaBiotics

License agreement for anti-fungal peptide treatment, Novexatin® Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that it has ...

Taro Pharmaceutical Industries Ltd (TARO) CEO Uday Baldota on 2018/19 First Half Results - Earnings Call Transcript

Taro to Announce Second Quarter Results on November 5, 2018

Earnings Call to be Conducted Tuesday, November 6 at 8:00 am EST Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results...

Taro Pharmaceutical Industries Ltd TARO Financial and Strategic SWOT Analysis Review [Report Updated: 18092018] Prices from USD $125

Taro Pharmaceutical Industries Ltd TARO Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been c...

Taro Pharmaceutical Industries Ltd TARO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryTaro Pharmaceutical Industries Ltd Taro, a subsidiary of Sun Pharmaceutical Industries Ltd, research develops and markets healthcare products. The company manufactures prescription drugs, nonpr...

Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of Vecuronium Bromide for Injection Due to the Presence of Particulate Matter Identified as Glass

Audience: Health Professional, Pharmacy Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium B...

PubMed Articles [573 Associated PubMed Articles listed on BioPortfolio]

Taro starch (Colocasia esculenta) and citric acid modified taro starch as tablet disintegrating agents.

The objective of the present work is to study the physicochemical and functional properties of taro starch (Colocasia esculenta) and to further modify the starch by treating with citric acid to obtain...

Conserving and Sharing Taro Genetic Resources for the Benefit of Global Taro Cultivation: A Core Contribution of the Centre for Pacific Crops and Trees.

This review article gives an account of the origin, domestication, and dispersal of taro, a staple food crop in many countries in the humid tropics and subtropics. Genetic diversity studies indicated ...

Stable isotope natural abundances (δC and δN) and carbon-water relations as drought stress mechanism response of taro (Colocasia esculenta L. Schott).

Taro (Colocasia esculenta L. Schott) is an important staple food crop in tropical and developing countries, having high water requirements. The purpose of this study was to evaluate the feasibility of...

Physical stabilities of taro starch nanoparticles stabilized Pickering emulsions and the potential application of encapsulated tea polyphenols.

In this research, Pickering emulsion stabilized by taro starch nanoparticles was successfully prepared, and the potential application of encapsulating tea polyphenols was investigated. The nanoparticl...

Analysis of Pin Milling of Pharmaceutical Materials.

Milling is an important process for tailoring the particle size distribution for enhanced dissolution, content uniformity, tableting, etc., specially for active pharmaceutical ingredients and excipien...

Clinical Trials [365 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distribute...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

A Therapeutic Equivalence Study of Two Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

The primary objectives are to establish the therapeutic equivalence of imiquimod cream 5%, manufactured by Taro Pharmaceuticals Inc. and Aldara (imiquimod) cream, manufactured by 3M, and t...

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in the treatm...

Companies [2229 Associated Companies listed on BioPortfolio]

 Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries develops, manufactures, and markets high-quality generic and branded pharmaceuticals, both prescription and over-the-counter, used by patients in countries around the wo...

Taro Pharmaceutical Ind.

Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing li...

Taro Pharmaceuticals U.S.A., Inc.

Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States.The U.S. has become Taro’s largest m...

Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integr...

More Information about " Taro Pharmaceutical Industries Ltd." on BioPortfolio

We have published hundreds of  Taro Pharmaceutical Industries Ltd. news stories on BioPortfolio along with dozens of  Taro Pharmaceutical Industries Ltd. Clinical Trials and PubMed Articles about  Taro Pharmaceutical Industries Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of  Taro Pharmaceutical Industries Ltd. Companies in our database. You can also find out about relevant  Taro Pharmaceutical Industries Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record